Sernova Corp.
TSX:SVA.TOBiotechnology
Healthcare
$0.14 -5.88%
-$0.01 today
- Market cap
- $50.98M
- Beta
- 0.66
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$0.03
52W Low $0.12High $0.21
Volume 0.55M
Average 0.12M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$15.12M
FY 2025 · Annual
Net Income
-$15.74M
FY 2025 · Annual
Income Statement
CAD
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 267.2K | 440K | 445.55K | 540.28K | 342.59K |
| Gross Profit | (267.2K) | (440K) | (445.55K) | (540.28K) | (342.59K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 4.64M | 16.9M | 32.26M | 22.36M | 7.28M |
| Selling, General & Admin | 2.29M | 7.83M | 8.46M | 8.97M | 7.5M |
| Operating Expenses | 6.94M | 24.75M | 41.13M | 31.84M | 14.78M |
| Depreciation & Amortization | 267.2K | 440K | 308.49K | 410.53K | 342.59K |
| EBITDA | (6.6M) | (24.54M) | (40.19M) | (31.25M) | (14.74M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (6.87M) | (24.18M) | (41.13M) | (31.84M) | (15.12M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 70.55K | 577.29K | 1.5M | 388.39K | 25.63K |
| Interest Expense | 58.37K | 118K | 32.08K | 586.86K | 754.81K |
| Other Income / Expenses | 1.09M | 1.01M | 1.5M | (347.04K) | (711.01K) |
| Income Before Tax | (6.97M) | (24.42M) | (39.63M) | (32.19M) | (15.84M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 58.37K | 118K | (629.02K) | 7K | (92.19K) |
| Net Income | (7.02M) | (24.54M) | (39M) | (32.19M) | (15.74M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.03) | (0.09) | (0.13) | (0.10) | (0.05) |
| EPS (Diluted) | (0.03) | (0.09) | (0.13) | (0.10) | (0.05) |
| 245.52M | 273.59M | 303.33M | 306.96M | 328.29M | |
| 245.52M | 273.59M | 303.33M | 306.95M | 328.29M |
SVA.TO Earnings Waterfall · TTM
TSX:SVA.TO · Revenue to Net Income
Key Ratios
EPS$-0.04
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-5.0
P/S Ratio0.0
Analysis
$0 of revenue converted into -$11.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.04, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
How much revenue does SVA.TO generate?
Sernova Corp. (SVA.TO) reported $0.00 of revenue in fiscal 2025.
Is SVA.TO profitable?
Sernova Corp. (SVA.TO) reported -$15.74M of net income.
Continue the stock analysis
Jump to another research area for this company.